Treatment Heterogeneity for Survival Outcomes
Yizhe Xu, Nikolaos Ignatiadis, Erik Sverdrup, Scott Fleming, Stefan, Wager, Nigam Shah

TL;DR
This paper reviews and guides the application of metalearners for estimating treatment heterogeneity in survival outcomes, supported by simulations and real data reanalysis, and introduces an R package for implementation.
Contribution
It provides a comprehensive summary, practical guidance, and an R package for applying metalearners to estimate treatment heterogeneity in survival data from RCTs.
Findings
Simulation study shows varying performance based on data complexity
Reanalysis questions the validity of previously identified effect modifiers
Provides practical recommendations for causal inference in survival analysis
Abstract
Estimation of conditional average treatment effects (CATEs) plays an essential role in modern medicine by informing treatment decision-making at a patient level. Several metalearners have been proposed recently to estimate CATEs in an effective and flexible way by re-purposing predictive machine learning models for causal estimation. In this chapter, we summarize the literature on metalearners and provide concrete guidance for their application for treatment heterogeneity estimation from randomized controlled trials' data with survival outcomes. The guidance we provide is supported by a comprehensive simulation study in which we vary the complexity of the underlying baseline risk and CATE functions, the magnitude of the heterogeneity in the treatment effect, the censoring mechanism, and the balance in treatment assignment. To demonstrate the applicability of our findings, we reanalyze…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Health Systems, Economic Evaluations, Quality of Life · Statistical Methods in Clinical Trials
